Earnings Feed
Start Free
OSI PHARMACEUTICALS INC·4

Jun 7, 7:48 PM ET

WHITE JOHN P 4

4 · OSI PHARMACEUTICALS INC · Filed Jun 7, 2010

Insider Transaction Report

Form 4
Period: 2010-06-03
OSI PHARMACEUTICALS INCOSIP
WHITE JOHN P
Director
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−7,500$431,250→ 0 total
    Exercise: $28.65Exp: 2016-06-16→ Common Stock (7,500 underlying)
  • Disposition from Tender

    Common Stock

    2010-06-03$57.50/sh−12,823$737,323→ 5,500 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−10,000$575,000→ 0 total
    Exercise: $36.13Exp: 2011-03-13→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−7,500$431,250→ 0 total
    Exercise: $41.38Exp: 2012-03-12→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−6,000$345,000→ 0 total
    Exercise: $15.02Exp: 2013-03-18→ Common Stock (6,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−7,500$431,250→ 0 total
    Exercise: $38.61Exp: 2014-03-16→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−7,500$431,250→ 0 total
    Exercise: $45.60Exp: 2015-03-15→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−3,000$172,500→ 0 total
    Exercise: $30.39Exp: 2013-06-13→ Common Stock (3,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−3,000$172,500→ 0 total
    Exercise: $36.25Exp: 2014-06-12→ Common Stock (3,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2010-06-03$57.50/sh−7,500$431,250→ 0 total
    Exercise: $38.63Exp: 2015-06-10→ Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]These stock options were canceled in exchange for a cash payment in accordance with the Agreement and Plan of Merger, dated as of May 16, 2010, among OSI Pharmaceuticals, Inc., Astellas Pharma Inc., Astellas US Holding, Inc. and Ruby Acquisition, Inc. The cash payment made with respect to each stock option equals the product of (x) the number of shares issuable upon the exercise of such option multiplied by (y) the excess, if any, of $57.50 over the exercise price per share for such option.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT